Abstract EPR oximetry using implantable resonators allows measurements at much deeper sites than are possible with surface resonators (> 80 vs. 10 mm) and achieves greater sensitivity at any depth. We report here the development of an improved technique that enables us to obtain the information from multiple sites and at a variety of depths. The measurements from the various sites are resolved using a simple magnetic field gradient. In the rat brain multiprobe implanted resonators measured pO 2 at several sites simultaneously for over 6 months under normoxic, hypoxic, and hyperoxic conditions. This technique also facilitates measurements in moving parts of the animal such as the heart, because the orientation of the paramagnetic material relative to the sensing loop is not altered by the motion. The measured response is fast, enabling measurements in real time of physiological and pathological changes such as experimental cardiac ischemia in the mouse heart. The technique also is quite useful for following changes in tumor pO 2 , including applications with simultaneous measurements in tumors and adjacent normal tissues.
Introduction
EPR has been developed for over several decades and applied successfully for detecting and monitoring radical levels in chemical and biological materials [1] [2] [3] . L-band EPR, in particular, has been used for measuring and monitoring tissue pO 2 in rodents and in patients with subcutaneous tumors and skin cancer [4] [5] . In spite of these successful applications, L-band EPR has some limitations such as being limited to measure at tissue depths of no more than 10 mm and considerable noise when measurements are made in organs that may move during the measurement, such as the beating heart. We have developed the implantable resonators for EPR to overcome these limitations, to enhance detection, and to measure pO 2 in diverse tissues/organs. The techniques also have applicability for other types of measurements by EPR, including biophysical parameters, free radicals, redox state, and dosimetry.
Materials and Methods
The implantable resonator has two sets of loops, a larger loop on one end and one or more small loops on the other end. The large loop is used to couple inductively to the L-band EPR spectrometer. The small loop contains lithium phthalocyanine (LiPc) or other oxygen sensitive paramagnetic materials and is coated with a highly gas permeable, biocompatible material (in the studies we used Teflon) [6] . The small loops are implanted in the sites of interest.
All animal procedures were conducted in accordance with the NIH Guide and approved by the Institutional Animal Care and Use Committee of Dartmouth Medical School. The implantable resonators were placed surgically into regions based on the experimental designs. To measure pO 2 in the heart, a short single probe resonator was used. The large coupling loop was placed under the skin close to the chest, while the small tip was inserted into the myocardial muscle near the coronary artery of the mouse. After surgery, the animal was allowed to recover for a 2 days before the EPR measurements. To create temporary cardiac ischemia, a fine ligature was placed around the artery that could be tightened remotely to temporarily occlude the blood flow. For brain pO 2 , either a single or a multi-probe resonator was inserted into the targeted sites, while the large loop was placed on the scalp. Rats were allowed to recover for at least 1 day before hypoxic, normoxic, hyperoxic studies of brain tissue or measurements in tumors. The tumors were established by injection of a suspension of F98 glioma cells (500,000 cells/10ml, 7ml/site) intracranially at a depth of 5$6 mm from the skull into the vicinity of the sensing tip. To qualitatively assess the tumor growth and size, we used MRI to acquire images 1 day before and 19 days after the injection of F98 cells. MRI images were acquired on a 7T Varian console interfaced to a Magnex horizontal bore magnet using a birdcage coil in transmit/receive mode. T1-weighted images were acquired using a spin-echo sequence (repetition time, 0.7 s; excitation time, 9 ms; slice thickness, 1 mm; field of view, 4 Â 4 cm; number of signal averages, 2; and matrix size, 128 Â 128). The total data acquisition time was 3 min, 12 s for each image set.
EPR measurements were carried out using an L-band EPR spectrometer. Rats or mice were anesthetized with $2% isoflurane/air and were placed in the magnet with the resonator sensing tip in the center of the magnet. The loop of the external resonator was placed over the coupling loop of the implantable resonator. For multi-probe resonators, a single dimensional magnetic gradient was applied to separate the EPR signals from each probe. For normoxia, the inhaled gas was 30% O 2 ; to induce mild hypoxia the gas was lowered to 15% O 2 , and for hyperoxia we used carbogen (95% O 2 /5% CO 2 ). Figure 1 shows the myocardial pO 2 during baseline and ischemic conditions. Under normoxia, the mouse had a very stable pO 2 of about 40 mmHg. With occlusion, the pO 2 immediately decreased to 15 mmHg. Upon reperfusion, the pO 2 increased but did not reach the baseline level. For repeated brain pO 2 measurements, a 3-probe resonator was placed into a rat brain with the following coordinates: Left, 3.5 mm with depth at 3.5, 1.5 mm with depth at 2.5 mm to the midline; right 1.5 mm with depth at 2.5 mm to the midline. The pO 2 measurement was started the second day after the resonator implantation and continued for up to 180 days, Fig. 2 . In the first several days, tissue pO 2 showed Fig. 1 Measurement of myocardial pO 2 using a short single probe resonator. a: baseline pO 2 of a mouse heart. b: pO 2 under several different conditions: baseline, ischemia and reperfusion. c: positioning of the external resonator over the large loop of the implantable resonator that was under the skin. d: a typical EPR spectrum (baseline pO 2 ). e: location of the resonator probe Fig. 2 Repeated, long term pO 2 measurements with a 3-probe resonator implanted in a rat brain. The measurements were started the second day after implantation and continued for up to 180 days. a: 30% O 2 for baseline, b: 15% O 2 for hypoxia and c: carbogen for hyperoxia a large variation, which is likely due to the trauma associated with the insertion of the probes.
Results
After 2 weeks, the tissue pO 2 stabilized and could be measured with a good signal to noise ratio in all measurements. The tissue pO 2 of a rat breathing 30% O 2 was 45 mmHg (Fig. 2a) . Under 15% O 2 , the rat had a pO 2 of 15 mmHg (Fig. 2b) . When the rats breathed carbogen, the pO 2 increased to around 100 mmHg, (Fig. 2c) . Importantly, there was no large variation in brain tissue pO 2 while breathing 30% O 2 from day 56 to 180. These results demonstrate the ability of this technique to monitor brain tissue oxygenation in both normal and pathologic conditions for prolonged periods of time.
For measuring the brain pO 2 dynamic changes, we used a 4-probe resonator implanted as indicated in Fig. 3 . When the oxygen concentration was changed from 30% to room air, the brain pO 2 decreased gradually and reached a stable level after 10 minutes. Although all four sites did not have exactly the same pO 2 values, the dynamic patterns were very similar. When the oxygen level was changed from room air to 15% O 2 , the tissue pO 2 in all sites reduced to much lower values (17$22 mmHg). During a carbogen challenge, the two lateral sites had a much larger pO 2 response, compared to the two medial sites.
We inserted one-probe implantable resonators into the rat brain, at a depth of 5$6 mm from the brain surface, for monitoring the pO 2 during tumor growth. Figure 4a shows the MRI images of a sham injected rat 7 days before and 19 days after an equal volume of culture media injection. There was no obvious morphological change in the MRI images. The pO 2 stayed at a very similar level (40$55 mmHg) across the measurements (Fig. 4b) . The changes in the MRI for the rats with tumors are shown in Fig. 4a , the tumor grew around the resonator tip. There was a decrease of the pO 2 in the tumor sites; the pattern of the decrease differed in different rats and showed different pO 2 decline rates (Fig. 4b) . On day 25 after cell inoculation, all rats received carbogen. The brains in the sham injected rats had a robust response to the carbogen while the tumors had almost no response.
Discussion
We have successfully used implantable resonators to measure tissue pO 2 in the heart and the brain under diverse conditions. The use of the implantable resonators in the beating heart enabled us to overcome the problems usually encountered when trying to make measurements of pO 2 in a moving organ. Previously, to measure myocardial pO 2 , we had to carry out a large amount of data averaging to reduce the noise induced by the relative motion between the paramagnetic material and the probe. This precluded measuring dynamic changes such as those associated with the acute induction of ischemia. Using a single or multi-probe resonator for long-term brain pO 2 measurements confirmed the very stable pO 2 in the targeted sites, and we were able to measure this Fig. 3 A four-probe implantable resonator used to measure dynamic responses in the rat brain to changes in inhaled oxygen levels. The resonator was inserted at the following coordinates: AP, 0 mm; ML, 2.0 mm and 3.5 mm, DV, 5.5 mm. Oxygen was delivered through a nose cone to the rat. Plots from left to right:
brain pO 2 during change from 30% O 2 to air, from air to 15% O 2 , and from air to carbogen for days and months. Such measurements would be very difficult to do with polarographic electrodes or the OxyLite system. Another very important advantage of this technique is the feasibility of carrying out oximetry at any depth. This extends the advantages of EPR oximetry to almost any site where the resonator can be implanted. The implantable resonators, once inserted, allow repeated pO 2 measurements with excellent time resolution and can be repeated across days or weeks.
